← Leaderboards
Jay A Berzofsky
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsVirusResponseMucous MembraneVaccinesAntigensLigandsT-LymphocyteCytokineDoseMucosal ImmunityImmune ResponseAdjuvantInterleukin-15PreventT Cell ResponseImmunityEpitopesMacacaClinical TrialsMucosal VaccineHiv VaccineModificationMalignant Neoplasms
Grant awards (37)
Vaccine and immunotherapy strategies for cancer and viruses causing cancer$596,948
ZIA · FY2025 · CA · contact PI
Vaccine strategies for HIVAIDS$397,966
ZIA · FY2025 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$331,638
ZIA · FY2025 · CA · contact PI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer$1,733,876
ZIA · FY2024 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$1,300,408
ZIA · FY2024 · CA · contact PI
Vaccine strategies for HIVAIDS$1,300,408
ZIA · FY2024 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$2,147,209
ZIA · FY2023 · CA · contact PI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer$2,147,209
ZIA · FY2023 · CA · contact PI
Vaccine strategies for HIVAIDS$1,073,604
ZIA · FY2023 · CA · contact PI
Vaccine strategies for HIVAIDS$2,640,125
ZIA · FY2022 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$1,200,057
ZIA · FY2022 · CA · contact PI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer$960,045
ZIA · FY2022 · CA · contact PI
Vaccine strategies for HIVAIDS$2,867,414
ZIA · FY2021 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$1,303,369
ZIA · FY2021 · CA · contact PI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer$1,042,696
ZIA · FY2021 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$4,614,298
ZIA · FY2020 · CA · contact PI
Studies of the SARS-CoV-2 Spike Protein$512,699
ZIA · FY2020 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$5,208,974
ZIA · FY2019 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$4,544,275
ZIA · FY2018 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,608,886
ZIA · FY2017 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,386,683
ZIA · FY2016 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,304,387
ZIA · FY2015 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,464,609
ZIA · FY2014 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,571,550
ZIA · FY2013 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,465,506
ZIA · FY2012 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,497,776
ZIA · FY2011 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$3,863,029
ZIA · FY2010 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$2,741,261
ZIA · FY2009 · CA · contact PI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS$1,800,256
Z01 · FY2008 · CA · contact PI
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS$2,029,401
Z01 · FY2007 · CA · contact PI
Antigen-specific T-cell activation, application to vacci$0
Z01 · FY2006 · SC · contact PI
Antigen-specific T-cell activation, application to vacci$0
Z01 · FY2005 · SC
Antigen-specific T-cell activation, vaccines for Cancer$0
Z01 · FY2004 · SC
Antigen-specific T-cell activation, application to vacci$0
Z01 · FY2003 · SC
Antigen-specific T-cell activation, application to vacci$0
Z01 · FY2002 · SC
Antigen-specific T-cell activation--cancer /AIDS vaccine$0
Z01 · FY2001 · SC
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS$0
Z01 · FY2000 · SC